Recovery, performance, and the long view.
Peptide therapy, platelet-rich plasma (PRP), and MSC-derived exosomes — used as standalone protocols or layered with hormone and functional medicine work. The goal is the same: support the body's own repair, recovery, and longevity systems with targeted, evidence-based interventions.
Working with the body, not around it
Regenerative medicine isn't a single therapy — it's a category of tools that help your body do what it already knows how to do, more efficiently. Targeted peptides for signaling. PRP for tissue-specific growth factors. Exosomes for cell-to-cell repair messages. Each one delivered against a clear clinical picture, not a wishlist.
We use these protocols on their own when that's the right call, and layered with hormone optimization, functional medicine, and advanced diagnostics when the situation calls for it. The throughline is precision: the right intervention, at the right dose, for the right patient.
Peptide Therapy
Specific peptides for performance, recovery, sleep, body composition, and longevity. Tesamorelin, BPC-157, and more — used clinically and individually.
Peptide details →PRP Therapy
Platelet-rich plasma drawn from your own blood and concentrated for joint, tendon, and soft-tissue recovery.
PRP details →Two tools, used for different jobs
We work with two distinct regenerative tools in this category: pure umbilical cord mesenchymal stem cells (UCMSCs), and MSC-derived exosomes. They are not interchangeable, and we don't position one as universally better than the other. They have different mechanisms, different delivery profiles, and different clinical situations where each may be appropriate.
UCMSCs are live mesenchymal stem cells. They have been studied for their regenerative properties — cell-to-cell signaling, immune modulation, and tissue-repair support. Used in selected protocols where a clinician determines they may be appropriate.
Exosomes are small vesicles released by mesenchymal stem cells. They carry growth factors, cytokines, mRNA, peptides, and proteins — the signaling payload that stem cells use to communicate repair instructions. Because exosomes are acellular, they have a different biological profile than live cells: lower immunogenicity, no replication potential, smaller size, and the ability to cross certain biological barriers. They can be administered by injection, IV infusion, or topically depending on protocol.
UCMSCs and exosomes have been shown in research settings to support regenerative processes. They may potentially benefit selected patients as part of a broader clinical plan. They are not a guaranteed treatment for any specific condition, and outcomes vary. Patrick Fisher, PA-C, evaluates each case individually — history, labs, imaging, and goals — to determine whether a regenerative protocol involving either tool is appropriate, and which one(s) fit the situation.
Where we use them
- Reducing systemic inflammation and supporting tissue repair
- Accelerating recovery from injury, surgery, or chronic degeneration
- Modulating immune function in patients with chronic inflammatory burden
- Supporting longevity protocols focused on cellular health and aging
- Hard-to-reach tissues that benefit from IV-deliverable, barrier-crossing therapy
Like every regenerative protocol we offer, exosome therapy is paired with diagnostics and a clinical plan — not prescribed in isolation.
Patients who want their body to recover like it used to.
Athletes recovering from training. Patients dealing with persistent joint or tendon issues. People in their 40s, 50s, 60s+ who want to keep doing the things they love without long recovery curves. Regenerative medicine isn't a magic bullet — but used thoughtfully, alongside the right diagnostics, it can be the difference between feeling 50 and feeling 35.